Can Efzofitimod Reduce Steroid Dependency in Patients With Sarcoidosis?
Efzofitimod, a biologic immunomodulator, reduces steroid dependency and improves lung function in pulmonary sarcoidosis, offering hope for a novel treatment.
Read MoreSep 27, 2023
Efzofitimod, a biologic immunomodulator, reduces steroid dependency and improves lung function in pulmonary sarcoidosis, offering hope for a novel treatment.
Read MoreSep 27, 2023
Gefapixant, a P2X3 receptor antagonist, improved chronic cough severity and QOL, but 13% of patients discontinued due to taste-related side effects.
Read MoreSep 27, 2023
Long-term CPAP use in patients with obstructive sleep apnea linked to lower cardiovascular death risk and improved outcomes in real-world study.
Read MoreSep 27, 2023
Extended sotatercept as an add-on treatment for pulmonary arterial hypertension maintained long-term benefit, with low treatment-related discontinuation.
Read MoreSep 27, 2023
Myeloid inflammation and complement activation are linked to long COVID symptoms; distinct profiles observed in cognitive impairment and GI symptoms.
Read MoreSep 27, 2023
An investigational drug, BMS-986278, reduced ppFVC decline in progressive pulmonary fibrosis, regardless of background therapy.
Read MoreSep 27, 2023
Among patients with severe asthma, the need for biologic therapy varies by clinical stage. Mepolizumab is the preferred choice.
Read MoreSep 27, 2023
Coronary artery calcification can effectively stratify risk for all-cause and cardiovascular (CV) mortality in people with obesity with no prior CV disease.
Read MoreSep 26, 2023
Early-life exposures affect pediatric respiratory health, but healthy lifestyle behaviors during pregnancy can mitigate these risks.
Read MoreSep 26, 2023
Maturing infant gut microbiota is associated with lower childhood risk for allergy-related wheezing and asthma.
Read MoreSep 26, 2023
Patients with severe eosinophilic asthma taking benralizumab may reduce high-dose inhaled corticosteroids/formoterol while maintaining symptom control.
Read MoreSep 26, 2023
Gabapentinoid use in patients with COPD increases the risk for severe exacerbation by almost 50%, underscoring the need for coordinated care.
Read MoreSep 26, 2023
Diesel pollution increases Aspergillus fumigatus resistance to itraconazole by over 64 times, highlighting the need to identify resistance mechanisms.
Read MoreSep 26, 2023
Serum sRAGE levels differentiate mild COPD from chronic bronchitis, offering potential as a diagnostic tool and therapeutic target.
Read MoreSep 26, 2023
Elevated heart rate and bilateral emboli were associated with hospitalization in low-risk patients with pulmonary embolism in the ED.
Read MoreSep 26, 2023
To curb inflation and turbulent markets, the US Federal Reserve has marked 2023 with rising...
Read MoreSep 25, 2023
A real-world study confirms survival outcomes of atezolizumab plus chemotherapy in extensive-stage small cell lung cancer.
Read MoreSep 22, 2023
Race alone is not a biological risk factor of all-cause mortality in patients with COPD; other environmental and community factors may contribute.
Read MoreSep 21, 2023
High-MELD living-donor liver transplants show acceptable outcomes, similar to deceased-donor transplants, offering hope for reducing donor shortages.
Read MoreSep 20, 2023
Lower tumor grade, younger age, and certain demographics are linked to better survival in patients with hepatocellular carcinoma with bone metastases.
Read More